The Trump Effect: Why Some Stocks are Soaring While Others Take a Massive Haircut
Jim Cramer warns that the U.S. is starting to feel like a 'command economy' as White House policy creates massive winners and losers. From a healthcare bloodbath to a steel and steel-toed boot victory lap, here is who is feeling the heat.
What Happened
If you thought the stock market was just about earnings reports and interest rates, Jim Cramer has a wake-up call for you. On Tuesday, the 'Mad Money' host highlighted a stark reality: the White House has become the ultimate market mover. In a single session, we saw a brutal divide between companies getting a government-mandated discount and those riding a wave of deregulation.
The biggest shock came from the healthcare sector. Shares of industry titans UnitedHealth and Humana didn't just dip—they plummeted over 20%. CVS Health, the parent company of Aetna, wasn't far behind with a 14% tank. The culprit? A surprise proposal from the administration for a 'nearly flat' reimbursement rate for Medicare Advantage plans in 2027. Wall Street was expecting a comfortable 4% to 6% increase. Instead, they got a cold shower that could cost these firms billions in federal payments.
On the flip side, General Motors and Nucor are finding that the current political climate is exactly the fuel they need. GM posted a massive earnings beat, sending shares up 8.75% in a single day, while Nucor continues to ride a 42% gain over the past year thanks to aggressive trade protections.
Quick Take
- Healthcare Bloodbath: UnitedHealth and Humana saw 20%+ drops after the government proposed flat Medicare reimbursement rates instead of the expected 4-6% hike.
- Gas Power is Back: General Motors (GM) jumped 8.75% as deregulation allows them to focus on profitable gas-powered trucks without the heavy burden of buying EV credits.
- Steel Fortress: Despite a slight earnings miss, Nucor remains up 42% year-over-year, shielded by 'Section 232' tariffs that keep foreign steel out and domestic profits in.
- The Command Economy: Cramer noted that the U.S. market is increasingly dictated by whether you are on the right or wrong side of the President's agenda.
Why It Matters
This isn't just about a bad day for insurance companies; it’s a shift in how we value stocks. For years, Medicare reimbursement increases were considered a 'sure thing,' something both parties signed off on almost automatically. Cramer noted, "I'm honestly surprised it happened because both political parties have checked off on these price increases for years... It’s like by rote."
When the government changes the rules of the game, the fundamental 'moat' of a company can evaporate overnight. For GM, the benefit is the removal of 'red tape' costs. Under the current administration's more lenient environmental stance, GM doesn't have to subsidize its electric transition as aggressively, allowing CEO Mary Barra to 'take a victory lap' on current profits. For Nucor, the government acts as a bodyguard, using tariffs to ensure they don't have to compete with cheaper imported steel.
Investors now have to ask a new question before buying a stock: Is this company a 'friend' or a 'target' of the current administration? The answer could be the difference between a 20% gain and a 20% loss.
The Bottom Line
In today's market, a single policy shift from Washington can be more powerful than a decade of corporate strategy, turning blue-chip stalwarts into falling knives and old-school manufacturers into market darlings.